Results 31 to 40 of about 211,869 (297)

The characteristics of novel dosage forms [PDF]

Hemijska Industrija, 2003
The objective of pharmaceutical-technological development is to find a procedure of transforming an active substance (a drug) into a drug dosage form which is not only acceptable for application, but also enables the active substance to be released ...
Milić-Aškrabić Jela, Petrović Slobodan D.   +1 more
doaj   +1 more source

The use of machine learning methods in the development of nasal dosage forms with cerebroprotective action

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2021
In order to save resource of active pharmaceutical ingredients and excipients, in the early stages of research, when planning an experiment, it is advisable to use data of the predicted and experimental physicochemical properties stored in different ...
B. S. Burlaka, I. F. Bielenichev
doaj   +1 more source

Altering dosage forms for older adults [PDF]

, 2018
Swallowing difficulties in older adults present challenges for medication management, particularly as polypharmacy is so common. It is also important to review the patient's swallowing difficulties and medication management regularly.
Glass, Beverley D., Selina Taylor, Beverley D Glass, Taylor, Selina   +3 more
core   +1 more source

The Effect of Microcrystalline Cellulose–CaHPO₄ Mixtures in Different Volume Ratios on the Compaction and Structural–Mechanical Properties of Tablets

Pharmaceutics
Using microcrystalline cellulose (MCC) with plastic behaviour and calcium phosphate anhydrous (CaHPO4) with brittle behaviour under compaction is very popular in the pharmaceutical industry for achieving desirable structural–mechanical properties of ...
Valentyn Mohylyuk, Artūrs Paulausks, Oskars Radzins, Liga Lauberte   +3 more
doaj   +1 more source

Formulation and Characterization of Felodipine as an Oral Nanoemulsions

Iraqi Journal of Pharmaceutical Sciences, 2021
Felodipine is a calcium-channel blocker with low aqueous solubility and bioavailability. Lipid dosage forms are attractive delivery systems for such hydrophobic drug molecules.
Sumaya B. Hamed, Shaimaa N. Abd Alhammid
doaj   +1 more source

Predicting Drug Loading Capacity for PLA-Amorphous Drug System Using Hansen Solubility Parameters

Pharmaceutics
Objective: In this work, we look at Hansen solubility parameters (HSPs) to predict drug miscibility with polymers, in order to create a saturated amorphous drug phase.
Artūrs Paulausks, Artjoms Iljičevs, Jurga Bernatoniene, Līga Pētersone, Konstantīns Logviss   +4 more
doaj   +1 more source

Novel pharmaceutical dosage forms of analgesics [PDF]

Arhiv za farmaciju, 2018
Among novel pharmaceutical dosage forms of analgesics, whose number and diversity are continuously increasing over the past two decades, of particular importance are transdermal opioid analgesics (fentanyl, buprenorphine) for the treatment of chronic ...
Đekić Ljiljana, Primorac Marija
doaj   +1 more source

Formulation Challenges and Strategies to Develop Pediatric Dosage Forms

, 2022
The development of pediatric-specific dose forms is particularly difficult due to a variety of factors relating to pediatric population differences from adult populations. The buccal dosage form is considered a good alternative to oral dosage form if the
Wedad A. Malkawi, Salam AbuLaila, Wedad Malkawi, Enas AlRafayah, Abeer Al-Ghananeem, Abeer M. Al-Ghananeem, Mohammad AlHazabreh   +6 more
core   +1 more source

Development of Orally Disintegrating Tablets of Standardized Rhodiola rosea Extract

Pharmaceuticals
Background/Objectives: Rhodiola rosea L. (Crassulaceae), a perennial adaptogenic herb native to Northern Europe, Asia, and North America, is renowned for its therapeutic properties attributed to phenolic compounds including flavonoids, phenylethanoids ...
Oxana Brante, Rihards Talivaldis Bagons, Santa Niedra, Austris Mazurs, Baiba Mauriņa, Jurga Bernatoniene, Konstantins Logviss   +6 more
doaj   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source